Abstract
Rationale
Whilst dopamine agonist therapies can successfully manage the symptoms of diseases such as Parkinson’s disease (PD), fibromyalgia and restless leg syndrome, they can also cause impulse control and addiction disorders such as gambling disorder (GD). These compulsive behaviours seriously undermine the utility of such treatments.
Objectives
The objective of the study was to model this phenomenon using a rodent slot machine task (rSMT) in order to investigate the neurobiological basis underlying such behavioural changes.
Methods
Male Long Evans rats were trained to perform the rSMT. The D2-like agonist ropinirole, or saline, was then delivered continuously for 28 days via osmotic mini-pump. The effects of ropinirole on baseline rSMT performance, as well as extinction and reinstatement sessions, were determined during this time. Brain samples from key frontostriatal regions implicated in GD and PD were then harvested immediately or after a 4-week washout period during which behaviour returned to pre-drug baseline.
Results
Ropinirole invigorated task performance, in that drug treatment resulted in a robust and sustained increase in the number of trials completed. Ex vivo analyses revealed that chronic ropinirole treatment led to a pattern of changes indicative of upregulation within the β-arrestin-AKT-GSK3β intracellular cascade, recently theorised to dominate D2-mediated signalling under hyperdopaminergic conditions, in the dorsal striatum, rather than the canonical PKA-dependent signalling pathway associated with D2 receptor activation.
Conclusions
Such findings provide novel insight into the role of dopamine signalling in mediating compulsive-like gambling behaviour and may inform more directed pharmacotherapies for the treatment of both idiopathic and iatrogenic GD.
Similar content being viewed by others
References
Balleine BW, Dickinson A (1998) Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology 37:407–419
Balleine BW, O’Doherty JP (2010) Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35:48–69
Barrus MM, Hosking JG, Zeeb FD, Tremblay M, Winstanley CA (2015) Disadvantageous decision-making on a rodent gambling task is associated with increased motor impulsivity in a population of male rats. J Psychiatry Neurosci 40:108–117
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217
Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261–273
Beaulieu JM, Gainetdinov RR, Caron MG (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166–172
Beaulieu JM, Gainetdinov RR, Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327–347
Blaszczynski A (1999) Pathological gambling and obsessive-compulsive spectrum disorders. Psychol Rep 84:107–113
Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M (2014) In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry 19:1305–1313
Breen RB, Zimmerman M (2002) Rapid onset of pathological gambling in machine gamblers. J Gambl Stud 18:31–43
Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev:CD003013
Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B (2010) Levodopa-induced dyskinesias in patients with Parkinson’s disease: filling the bench-to-bedside gap. Lancet Neurol 9:1106–1117
Chernoloz O, El Mansari M, Blier P (2009) Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34:651–661
Choliz M (2010) Experimental analysis of the game in pathological gamblers: effect of the immediacy of the reward in slot machines. J Gambl Stud 26:249–256
Clark CA, Dagher A (2014) The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling. Front Behav Neurosci 8:196
Cocker PJ, Winstanley CA (2015) Irrational beliefs, biases and gambling: exploring the role of animal models in elucidating vulnerabilities for the development of pathological gambling. Behav Brain Res 279:259–273
Cocker PJ, Dinelle K, Kornelson R, Sossi V, Winstanley CA (2012a) Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats. J Neurosci 32:15450–15457
Cocker PJ, Hosking JG, Benoit J, Winstanley CA (2012b) Sensitivity to cognitive effort mediates psychostimulant effects on a novel rodent cost/benefit decision-making task. Neuropsychopharmacology 37:1825–1837
Cocker PJ, Le Foll B, Rogers RD, Winstanley CA (2014) A selective role for dopamine D(4) receptors in modulating reward expectancy in a rodent slot machine task. Biol Psychiatry 75:817–824
Cocker PJ, Hosking JG, Murch WS, Clark L, Winstanley CA (2016a) Activation of dopamine D receptors within the anterior cingulate cortex enhances the erroneous expectation of reward on a rat slot machine task. Neuropharmacology 105:186–195
Cocker PJ, Lin MY, Barrus MM, Le Foll B, Winstanley CA (2016b) The agranular and granular insula differentially contribute to gambling-like behavior on a rat slot machine task: effects of inactivation and local infusion of a dopamine D4 agonist on reward expectancy. Psychopharmacology (Berl).
Cole BJ, Robbins TW (1987) Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology 91:458–466
Diskin KM, Hodgins DC (1999) Narrowing of attention and dissociation in pathological video lottery gamblers. J Gambl Stud 15:17–28
Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377–1381
Dowling N, Smith D, Thomas T (2005) Electronic gaming machines: are they the ‘crack-cocaine’ of gambling? Addiction 100:33–45
Eagle DM, Noschang C, d’Angelo LS, Noble CA, Day JO, Dongelmans ML, Theobald DE, Mar AC, Urcelay GP, Morein-Zamir S, Robbins TW (2014) The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. Behav Brain Res 264:207–229
Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481–1489
Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008) Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond Ser B Biol Sci 363:3125–3135
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E (2010) Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 35:591–604
Fontenelle LF, Mendlowicz MV, Versiani M (2005) Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 59:30–37
Frank MJ, Seeberger LC, O’Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940–1943
Grant JE, Odlaug BL, Schreiber LR (2014) Pharmacological treatments in pathological gambling. Br J Clin Pharmacol 77(2):375–381. doi:10.1111/j.1365-2125.2012.04457
Habib R, Dixon MR (2010) Neurobehavioral evidence for the ‘near-miss’ effect in pathological gamblers. J Exp Anal Behav 93:313–328
Hollander E, Pallanti S, Allen A, Sood E, Rossi NB (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiat 162:137–145
Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N (1999) Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res 838:51–59
Jentsch JD, Taylor JR (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146:373–390
Ladouceur R, Gaboury A, Dumont M, Rochette P (1988) Gambling-relationship between the frequency of wins and irrational thinking. J Psychol 122:409–414
Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O (1978) Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 273:59–61
Li YC, Gao WJ (2011) GSK-3 beta activity and hyperdopamine-dependent behaviors. Neurosci Biobehav Rev 35:645–654
Li YC, Wang MJ, Gao WJ (2012) Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3 beta signaling-mediated trafficking of GABA(A) receptors. J Neurochem 122:308–320
Limbrick-Oldfield EH, van Holst RJ, Clark L (2013) Fronto-striatal dysregulation in drug addiction and pathological gambling: consistent inconsistencies? Neuroimage Clin 2:385–393
Linnet J, Moller A, Peterson E, Gjedde A, Doudet D (2011) Dopamine release in ventral striatum during Iowa gambling task performance is associated with increased excitement levels in pathological gambling. Addiction 106:383–390
Matsukawa N, Maki M, Yasuhara T, Hara K, Yu G, Xu L, Kim KM, Morgan JC, Sethi KD, Borlongan CV (2007) Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats. Brain Res 1160:113–123
Michalczuk R, Bowden-Jones H, Verdejo-Garcia A, Clark L (2011) Impulsivity and cognitive distortions in pathological gamblers attending the UK National Problem Gambling Clinic: a preliminary report. Psychol Med 41:2625–2635
Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A (2004) S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther 309:936–950
Murch WS, Clark L (2016) Games in the brain: neural substrates of gambling addiction. Neuroscientist 22(5):534–545. doi:10.1177/1073858415591474
Nashatizadeh MM, Lyons KE, Pahwa R (2009) A review of ropinirole prolonged release in Parkinson’s disease. Clin Interv Aging 4:179–186
Pallanti S, Quercioli L, Sood E, Hollander E (2002) Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiat 63:559–564
Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650
Potenza MN (2006) Should addictive disorders include non-substance-related conditions? Addiction 101(Suppl 1):142–151
Potenza MN (2013) How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci 7
Rogers DC, Costall B, Domeney AM, Gerrard PA, Greener M, Kelly ME, Hagan JJ, Hunter AJ (2000) Anxiolytic profile of ropinirole in the rat, mouse and common marmoset. Psychopharmacology 151:91–97
Rokosik SL, Napier TC (2012) Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson’s disease and controls. Neuropsychopharmacology 37:1397–1408
Rossi M, Gerschcovich ER, de Achaval D, Perez-Lloret S, Cerquetti D, Cammarota A, Nouzeilles MI, Fahrer R, Merello M, Leiguarda R (2010) Decision-making in Parkinson’s disease patients with and without pathological gambling. Eur J Neurol 17:97–102
Schmidt TT, Rea E, Shababi-Klein J, Panagis G, Winter C (2013) Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder. Int J Neuropsychopharmacol 16:1083–1091
Schüll ND (2012) Addiction by design: machine gambling in Las Vegas. Princeton University Press, Princeton, NJ
Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593–1599
Szechtman H, Sulis W, Eilam D (1998) Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci 112:1475–1485
Terry P, Gilbert DB, Cooper SJ (1995) Dopamine receptor subtype agonists and feeding behavior. Obes Res 3(Suppl 4):515S–523S
Toneatto T, Blitz-Miller T, Calderwood K, Dragonetti R, Tsanos A (1997) Cognitive distortions in heavy gambling. J Gambl Stud 13:253–266
Tremblay M, Silveira MM, Kaur S, Hosking JG, Adams WK, Baunez C, Winstanley CA (2016) Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns. Eur J Neurosci. doi:10.1111/ejn.13332
Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:557–569
Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575–1579
Voon V, Potenza MN, Thomsen T (2007a) Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Curr Opin Neurol 20:484–492
Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007b) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212–216
Weintraub D, Potenza MN (2006) Impulse control disorders in Parkinson’s disease. Current neurology and neuroscience reports 6:302–306
Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30:121–127
Winstanley CA (2007) The orbitofrontal cortex, impulsivity, and addiction: probing orbitofrontal dysfunction at the neural, neurochemical, and molecular level. Ann N Y Acad Sci 1121:639–655
Winstanley CA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 164:1301–1321
Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176:376–385
Winstanley CA, Cocker PJ, Rogers RD (2011) Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a ‘near-miss’ effect. Neuropsychopharmacology 36:913–925
Zeeb FD, Robbins TW, Winstanley CA (2009) Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 34:2329–2343
Acknowledgments
This work was supported by an operating grant awarded to CAW from the Canadian Institutes of Health Research (CIHR). CAW also received salary support through the Michael Smith Foundation for Health Research and CIHR New Investigator Award program. PJC is funded through a graduate student award from Parkinson’s Society Canada. CAW has previously consulted for Shire on an unrelated matter.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The testing and housing of all animals was in accordance with the Canadian Council of Animal Care, and all experimental protocols were approved by the Animal Care Committee of the University of British Columbia.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Cocker, P.J., Tremblay, M., Kaur, S. et al. Chronic administration of the dopamine D2/3 agonist ropinirole invigorates performance of a rodent slot machine task, potentially indicative of less distractible or compulsive-like gambling behaviour. Psychopharmacology 234, 137–153 (2017). https://doi.org/10.1007/s00213-016-4447-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-016-4447-y